The Clinilabs team is comprised of industry leaders and experts in the field of clinical research. This team brings the best combination of scientific and operational experience to every project we run.

Gary Zammit, PhD - President and Chief Executive Officer

Gary Zammit, is the President & CEO of Clinilabs Drug Development Corporation, a full-service CRO that provides clinical drug development to industry, focusing on CNS therapeutics. Gary Zammit is a scientist and former academician who founded Clinilabs Drug Development Corporation in 2001, having the belief that there was an industry need for a specialty CNS CRO that could improve the way new drugs and medical devices are developed. Dr. Zammit is widely sought for his expertise in neuropsychiatric drug development. Gary has authored more than 230 original publications and 2 books, and has served as a reviewer and editor for well-known medical journals. He is committed to ensuring that Clinilabs Drug Development Corporation’s senior management remains involved in every project that we accept, so that clients have easy and immediate access to the leadership of a high-performance development team.

Jeff Mulchahey - Chief Development Officer

Jeff Mulchahey has more than 20 years of experience in drug development, having served as an academic clinical investigator, an IRB chair, and in functional area and strategic leadership roles in pharma and CRO settings. Jeff is currently the Chief Development Officer at Clinilabs, where he oversees business development and its interface with clinical development and operations.  Prior to joining Clinilabs, Jeff served as Senior Vice President of Clinical Development and Therapeutic Area Lead for Neurology at Syneos Health.  Within the past 10 years Jeff and his teams have led the clinical development of 8 FDA-approved new drugs in the CNS space.  A life-long devotee of the neurosciences, Jeff shares Clinilabs’ vision of being an industry leader in CNS drug development, emphasizing high-quality trial delivery combined with senior leadership engagement and accountability in the interest of developing new therapeutics for patients in need.

Jeff is a former academician who has authored more than 100 scientific publications, chapters, and research presentations.  He has been the recipient of NIH funding and served as a scientific reviewer for funding agencies and scientific journals.  Jeff completed his Bachelor of Science degree, doctorate degree, and fellowship training at Duke University, Emory University, and UCSF, respectively.

Eileen McAuley - Chief Operating Officer

Eileen McAuley has more than 25 years of clinical research experience, having occupied positions in operational and strategic leadership roles. She currently oversees Clinilabs Drug Development Corporation’s operations, and is responsible for the oversight of project management, monitoring services, data management, biostatistics, medical writing and our Phase 1 clinics. Most recently, Eileen served as Senior Vice President, Clinical Services, at Frontage Labs, a provider of Phase 1 clinical research and bioanalytic services. Prior to that, she was the COO at Integrium, a full service CRO for cardiovascular, metabolic, and dermatology trials.

Eileen began her career as a critical care nurse and progressed to serve in clinical operations roles of increasing responsibility, including roles as Director of Project Management and head of operations for specialty clinical organizations. She earned a master’s degree in public administration from Seton Hall University, with a focus on health policy and management. She received a Bachelor’s of science degree from Montclair State College in New Jersey.

Jerry Deptuch - Chief Information Officer

Jerry Deptuch is a seasoned Information Technology professional having achieved positions with increasing responsibility throughout his career. Jerry is committed to help set and lead the technology strategies of our organization in collaboration with the executive management team. With his hands-on approach, Jerry serves as an effective liaison between the technology department and the other business units within Clinilabs. Jerry is innovative in his approach to identify new technologies that can assist the organization in achieving its goals and objectives. Having a master’s degree in Mathematics, Jerry has a cost-effective approach in his methodologies to identify the resources needed to meet or exceed these goals and objectives.

As the Chief Information Officer, Jerry guides his team to create business value through technology, planning of business growth opportunities, and ensuring tech systems and procedures are in place to meet objectives while maintaining business efficiency and productivity at Clinilabs.

Nancy Cameron, MA - Vice President of Clinical Operations

Ms. Nancy Cameron has worked in the clinical research industry for over 25 years. She obtained her BS degree in Radiologic Science from the University of North Carolina at Chapel Hill and has a MA in Educational Administration. Nancy has proven abilities in the monitoring and management of Phase I to Phase IV Clinical Trials across a broad range of therapeutic areas, with an emphasis in central nervous system (CNS) drug development.  Her CNS experience has spanned from small, complex Phase 1 and II studies to Phase 3 global trials in Alzheimer’s disease, mild cognitive impairment, Parkinson’s disease, Multiple System Atrophy, Multiple Sclerosis, Attention Deficit Disorder, sleep, analgesia, and CNS rare diseases within adult, geriatric, and pediatric populations. Nancy began her clinical research career as a Clinical Research Associate. After five years of clinical monitoring, she moved to project management and has progressed to increasing roles of responsibilities.  At Clinilabs as Vice President of Clinical Operations, Nancy oversees and supports a specialty CNS group of project managers, monitors, and other study team members to ensure timely delivery and quality

Christina Saulys - Vice President, Project Solutions

As Vice President of Project Solutions, Chris oversees all Core Laboratory Projects under the Data Services umbrella. She has over three decades of clinical research experience as a clinician and manager in roles at both site and CRO in phase I-IV trials. Chris joined Clinilabs’ first central scoring team in 2001 as a Registered Polysomnographic Technologist. During her tenure, Chris has used her unique blend of knowledge and determination to develop, motivate and inspire a diverse team that has contributed to over 260 clinical trials and the development of every major sleep therapeutic marketed since 2001.

Chris has developed special expertise in many types of electronic data collection methods, analysis tools and decentralized trial solutions. Leading with unparalleled global support and collaboration, she has worked to establish one of the most comprehensive databases of certified CNS sites and investigators in the world. Chris has extensive experience in neuro-diagnostics and holds certifications as a Clinical Research Associate and Project Manager. She has also held Executive leadership roles in Education and Quality Improvement, global Clinical Trial Management and Senior Project Management. Chris holds a Bachelor’s degree from the University of Nevada, Reno, and is licensed and Registered as a Polysomnographic Technologist (RPSGT) and Registered Sleep Technologist (RST).

Jeanine M. Falinski, MBA - Vice President, Strategy and Corporate Development

Ms. Jeanine Falinski, Vice President of Marketing and Communications, has more than 15 years of experience in the pharmaceutical industry.  Jeanine graduated from Emerson College with a degree in New Media and Marketing.  She, later on, received her MBA in Pharmaceutical Management from the LeBow College of Business at Drexel University.  Jeanine joined Clinilabs in 2004 as a Manager of Subject Recruitment and continued on through positions of progressive responsibility including Senior Director of Marketing and Communications and Senior Director of Business Development.  In 2014, she joined Evolution Research Group as Senior Director of Business Development.  Later on, she joined Artcraft Health, a marketing agency devoted to patient engagement and recruitment in clinical trials.  In January of 2019, Jeanine returned to Clinilabs having gained valuable experience in other organizations and is excited to bring a new level of strategy and design to our team and our clients.

The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.

– Michael J. Fox